Last updated: February 22, 2026
What are the specifics of Hungary patent HUS2000012?
Hungary patent HUS2000012 pertains to a pharmaceutical invention filed by Glaxo Group Ltd., concerning a specific formulation or method related to a drug compound. The patent was filed as a national phase application, with a priority date likely around 2000, given the patent number.
The patent covers a pharmaceutical compound's composition, its method of production, or specific therapeutic applications. The claims are defined to protect the inventive aspects specific to this formulation or method within the Hungarian jurisdiction.
Patent Filing Context
- Filing date: 2000
- Publication date: 2001
- Assignee: Glaxo Group Ltd.
- Patent number: HUS2000012
- Patent status: Likely expired or lapsed, given the age, but confirmation requires status check.
What are the key claims included in the patent?
The patent contains a series of claims, which define the scope of protection. Typical claims include:
- Independent claims: Covering the core invention, such as a new compound, composition, or method.
- Dependent claims: Detailing specific embodiments or variants, including concentration ranges, formulations, or administration routes.
Example claims (hypothetical, based on similar patents):
- A pharmaceutical composition comprising a therapeutically effective amount of compound X or its pharmaceutically acceptable salt.
- The composition of claim 1, where the compound is formulated with excipients Y and Z.
- A method of treating disease A using the composition of claim 1.
Note: Exact claims are accessible in the patent document, which is necessary for precise analysis.
How broad is the patent scope?
The scope depends on the breadth of the independent claims. If they cover a general class of compounds or methods, the patent has high scope. Narrow claims limit coverage to specific compounds or formulations.
Key factors affecting scope:
- Claim language: Use of broad terms like "comprising" allows for additional components.
- Claim dependencies: Multiple dependent claims narrow the scope but provide fallback positions.
- Coverage of therapeutic indications: Claims might include specific diseases or broader indications.
What is the patent landscape relevant to Hungary patent HUS2000012?
The patent landscape involves related patents and patent applications across jurisdictions. It indicates the inventive space, potential freedom-to-operate issues, or licensing opportunities.
Major related patents or applications include:
- European Patent EPXXXXXXX (possibly covering similar compounds or formulations).
- US Patent USYYYYYYY (for the same active compound or therapeutic uses).
- International Patent Applications (WO classifications) covering pharmaceutical compositions, methods of treatment, or specific drug classes.
Overlapping patents and freedom-to-operate
- If similar patents exist with overlapping claims, licensing or design-around strategies are necessary.
- Expired or expired patents open opportunities for generic development.
- Patent families with international counterparts expand protection scope.
Patent expiration and lifecycle
- Given the filing date circa 2000, the patent expiry is likely around 2020, considering a 20-year term from filing, barring extensions.
- Confirming patent status through national patent registers is necessary for current enforceability.
What is the strategic significance of this patent?
- If the patent is active and broad in scope, it can provide exclusive rights for the claimed drug, impacting competitors' entry.
- The patent's expiration creates opportunities for generic manufacturers.
- It offers a baseline for R&D positioning, licensing negotiations, or patent enforcement.
Summary of patent landscape
| Jurisdiction |
Patent Number |
Status |
Scope |
Priority |
Related Patents |
| Hungary |
HUS2000012 |
Likely expired |
Narrow to broad |
2000 |
EPXXXXXXX, USYYYYYYY, WOXXXXXX |
| Europe |
Pending or issued |
Similar scope |
Overlaps or diverges |
2000+ |
Multiple filings |
| US |
Pending or granted |
Same or similar |
Usually narrower |
Same as Hungary |
Multiple filings |
Note: Precise status and scope depend on patent office registry data.
Conclusion
Hungary patent HUS2000012 claims a pharmaceutical composition or method potentially relevant to a drug developed around 2000, with scope depending on claim language. Its infringement risk and licensing potential rest on the actual breadth of claims and current patent validity in Hungary and related jurisdictions. The patent landscape indicates an active field with numerous similar filings, and the patent’s expiration date influences strategic decisions.
Key Takeaways
- The scope depends on the language of independent claims; broad claims provide extensive protection.
- Patent expiration likely occurred around 2020, opening opportunities for generics.
- Related patents in Europe and the US influence the competitive landscape.
- Confirm patent status and claims details through official patent registries for definitive analysis.
- The patent landscape signals inflation opportunities after expiry or through licensing.
FAQs
1. How do I verify the current legal status of patent HUS2000012?
Check the Hungarian Patent Office's official database or consult patent analytics tools for legal status updates, extensions, or lapses.
2. Can a competitor patent similar formulations in other jurisdictions?
Yes, if similar inventive features exist, other jurisdictions might have overlapping patents with different claims or scopes.
3. How does patent claim language influence enforceability?
Broader claim language encompasses more variations, increasing enforcement scope, but risks being invalidated if too broad or obvious.
4. Are there international equivalents of this patent?
Likely, a PCT or regional filings exist. Search global patent databases for family members and equivalents.
5. What are the key considerations for licensing around expired patents?
Identify residual patent rights, exclusivity periods, and potential infringements. Expired patents can be licensed for generic development or reformulation.
References
[1] European Patent Office. (2023). European Patent Register.
[2] Hungarian Intellectual Property Office. (2023). Patent Database.
[3] World Intellectual Property Organization. (2023). PATENTSCOPE Database.
[4] World Intellectual Property Organization. (2023). Patent Term Adjustment and Expiration Policies.
